Full disclosure: Dombey Capital is our own research service and our top pick here, for the reasons below. The section on where it falls short is there so you can judge whether it fits your process.
What Finviz does well, and why people look elsewhere
Finviz is a fast, free stock screener for US stocks, with heat maps, charts and a filter set that covers descriptive, fundamental and technical criteria. Its Elite plan, at $39.50 a month or $299.50 a year, adds real-time data, 8 years of financial statements instead of 3, unlimited saved presets, advanced charting, email and push alerts, and Excel or CSV export.
People look for an alternative for a handful of reasons:
- Coverage. Finviz is built around US listings. Investors who screen global stocks need another tool.
- History. Three years of statements on the free plan, eight on Elite. Longer histories need a different platform.
- Custom fields. Screens built on a formula, such as cash minus all liabilities divided by market value, are hard to express with fixed filters.
- Export and alerts. Both need Elite. Some investors would rather pay for a tool that also adds history and coverage.
- Ideas, not filters. Some readers do not want to run a screen at all. They want a short list of names someone has already checked.
Knowing which of these applies to you narrows the list quickly.
Quick comparison
| Tool | Best for | Key features | Price (as of October 2026) |
|---|---|---|---|
| Dombey Daily Phoenix ScreenerTop pick | Special situations before a dated catalyst | Curated daily shortlist in the DombeyAI Portal, with the Phoenix Report and Catalyst Briefing | Founding Membership $1,200/year; Standard Access $6.67/month (no screener); Public Archive free |
| Stock Rover | Deepest metric library | 400 to 800+ metrics, up to 20 years of fundamentals | Free plan; Premium $29/month billed annually ($34 monthly) |
| Koyfin | Flexible global screens | Unlimited screens and 10-year financials on Plus; custom formulas on Premium | Free; Plus $39/month, Premium $79/month billed annually |
| TradingView | Chart-led screening | Screeners across 150+ exchanges, 500+ fields | Free Basic; paid from $12.95/month billed annually |
| TIKR | Long histories and global data | Up to 30 years of financials, saved screens, fund holdings | Free; Plus $24.95/month to Ultimate $119.95/month |
| Yahoo Finance | Free basic screening with news | Screeners; ~40 years of statements and CSV downloads on Gold | Free; Bronze $95.40/year to Gold $479.40/year |
| Simply Wall St | Visual screening for newer investors | Snowflake-based screener, portfolio tracking | Free plan; see the vendor's pricing page |
| Seeking Alpha Premium | Screening on quant ratings | Quant ratings and screeners on 4,000+ stocks and ETFs | $299/year |
| Morningstar Investor | Rating-led long-term screens | Screening tools tied to Morningstar ratings | $34.95/month or $249/year |
| Zacks Premium | Estimate-revision screens | Zacks Rank, Premium Screens | See the vendor's pricing page |
How we compared these tools
We compared these tools from vendor documentation, pricing pages and public product pages, read on October 5, 2026. We did not use paid accounts for this article and make no claims about the results any screen produces.
The weights favor what matters when you screen for special situations and dated catalysts: balance-sheet filters, custom formulas and a way to see when the next event falls.
| Criterion | Weight | What it measures |
|---|---|---|
| Balance-sheet and value filters | 25% | Price-to-cash, price-to-book, debt and enterprise value filters, or a way to build them |
| Catalyst awareness | 20% | Earnings dates or event context beside the results |
| Custom formulas | 15% | Whether you can screen on your own calculated field |
| Depth of history | 15% | Years of financial statements behind each result |
| Coverage | 10% | US only or global listings |
| Price and free tier | 15% | What the free plan does and what the plan you need costs |
If you are a technical trader, weight charting and real-time data above balance-sheet filters, and TradingView moves to the top of the self-serve tools.
Quick picks by job
Best for special situations before a dated catalyst: Dombey Daily Phoenix Screener
The Daily Phoenix Screener is a shortlist, not a filter panel. Each trading morning it shows situations relevant to Dombey's coverage of special situations and dated catalysts, so you start from a short list rather than a blank filter panel. Use a self-serve screener alongside it for your own ideas.
Best for depth of metrics: Stock Rover
Up to 800-plus metrics and 20 years of fundamentals on its top individual plans.
Best for flexible global screens: Koyfin
Unlimited screens on Plus, custom formulas on Premium, and data on more than 100,000 global companies.
Best for chart-led screening: TradingView
Screeners and fundamentals beside the strongest charting in this list.
Best for long histories on a budget: TIKR
Global data on every paid plan and up to 30 years of financials.
Best free screener with news: Yahoo Finance
A familiar free starting point, with paid tiers for longer histories.
Best for newer investors: Simply Wall St
A visual screener that explains what each result means.
Best for screening on a quant rating: Seeking Alpha Premium
Screens built on Seeking Alpha's quant ratings.
Best for long-term, rating-led screens: Morningstar Investor
Screens tied to Morningstar's analyst ratings.
Best for estimate-revision screens: Zacks Premium
Ready-made screens around the Zacks Rank.
Full reviews
1. Dombey Daily Phoenix Screener
What it does. The Daily Phoenix Screener is a research resource inside the DombeyAI Portal, updated each trading morning, that shows situations relevant to Dombey's coverage of special situations and event-driven equities. It sits beside the weekly Phoenix Report, weekly Options Research, the Biweekly Catalyst Briefing and the Earnings Conviction Model. The method behind it is the same one explained in how to find stocks trading below net cash.
Best for. Investors who want a daily shortlist of special situations with a catalyst ahead, rather than a blank filter panel.
Pricing. The screener is part of Founding Membership at $1,200 a year. Standard Access, the lower-cost option at $6.67 a month, includes the Biweekly Catalyst Briefing and the public-research archive but not the screener. The Public Archive is free.
Pros
- Starts from a short list tied to Dombey's catalyst coverage, not a blank panel.
- Sits beside written research, so a name on the list can be followed into a full thesis.
- Every published thesis stays in the research archive.
Cons
- You cannot set your own filters.
- Coverage is limited to special situations.
- Only available on the highest tier.
Verdict: Our top pick for investors who screen for special situations before a catalyst. Keep a self-serve screener for everything else.
2. Stock Rover
What it does. A research, screening and portfolio platform. Its plans page lists 400 metrics and 300-plus screening capabilities on Premium, 700 metrics and 10 years of fundamentals on Premium Plus, and 800 metrics with 20 years of fundamentals on Ultimate.
Best for. Investors who build detailed screens and want them tied to a portfolio.
Pricing. A free plan for basic research. Premium is $348 a year ($29 a month billed annually) or $34 on monthly billing; Premium Plus $588 a year, Ultimate $948 and Ultimate Pro $1,788. Two-year billing is cheaper. Every plan has a 14-day free trial, though trial accounts cannot export to CSV.
Pros
- The largest metric library in this list.
- Long fundamental histories on higher plans.
- Brokerage integration for portfolio tracking.
Cons
- Screening needs a paid plan.
- A long learning curve.
Verdict: The best self-serve replacement if Finviz's filters feel too thin.
3. Koyfin
What it does. A data, charting and dashboard platform with a stock and ETF screener and coverage of more than 100,000 global companies on paid plans.
Best for. Investors who screen global stocks or want to screen on their own formulas.
Pricing. Free with 2 screens, 2 watchlists and 2 years of financials. Plus is $39 a month billed annually, with unlimited screens, 10 years of financials and estimates, and filings and transcripts. Premium is $79 a month billed annually and adds unlimited custom data and formulas. Koyfin says annual billing saves up to 30% against monthly billing.
Pros
- Global coverage.
- Custom formulas on Premium.
- Filings and transcripts one click from the screen.
Cons
- The free plan's 2 screens run out quickly.
- Custom formulas need Premium.
Verdict: The best fit for global or formula-based screens.
4. TradingView
What it does. A charting platform with stock, ETF and crypto screeners covering more than 150 exchanges in more than 50 countries and over 500 fundamental and technical fields on paid plans. Paid plans include 20 years of annual and 8 years of quarterly financials.
Best for. Investors who screen and then go straight to the chart.
Pricing. A free Basic plan. Billed annually: Essential $12.95 a month, Plus $29.95, Premium $59.95 and Ultimate $199.95. Paid plans also include a growing allowance of AI screener requests.
Pros
- Wide international coverage.
- The strongest charting in this list.
Cons
- Fundamental analysis is secondary to charts.
- Many features are spread across several plan tiers.
Verdict: The pick for chart-led screening across many markets.
5. TIKR
What it does. A fundamentals platform with a screener on every plan, global data on paid plans, transcripts and fund holdings.
Best for. Screens that depend on long financial histories or non-US stocks.
Pricing. Free covers US stocks with 5 years of history and 1 saved screen. Plus is $24.95 a month with 10 saved screens, Pro $54.95 with 30, and Ultimate $119.95 with unlimited saved screens and 30 years of financials. Annual billing is available, with a 14-day money-back guarantee.
Pros
- Long histories at a modest price.
- Global coverage on every paid plan.
Cons
- The screener is less central than on Finviz or Stock Rover.
- No charting depth.
Verdict: Strong value for fundamentals-first screening.
6. Yahoo Finance
What it does. Free quotes, news, portfolios and screeners, with paid tiers that add research and data.
Best for. A free screen alongside the news you already read.
Pricing. Free. Bronze is $95.40 a year, Silver $239.40 with research reports and fair value analysis, and Gold $479.40 with about 40 years of financial statements, CSV downloads and a Smart Money Screener.
Pros
- Free and familiar.
- Gold offers very long statement histories.
Cons
- Screening is a side feature.
- The best data sits on the top tier.
Verdict: Fine for occasional free screens.
7. Simply Wall St
What it does. A visual research platform built around the Snowflake summary, with a screener and portfolio tracking using S&P Global data.
Best for. Newer investors who want screen results explained visually.
Pricing. A free plan shows only the top 4 screener results and 5 company reports a month. Premium and Unlimited show unlimited results; prices were not shown on the plans page, so see the vendor's pricing page. A 7-day Premium trial is offered.
Pros
- Easy to read.
- A permanent free plan.
Cons
- The free screener is heavily limited.
- Visual scores hide the underlying assumptions.
Verdict: A gentle start for newer investors.
8. Seeking Alpha Premium
What it does. Data-driven stock ratings and screeners, AI research tools and analysis on more than 4,000 stocks and ETFs, built on Seeking Alpha's Quant System.
Best for. Investors who want to screen on a ready-made quant rating and then read analysis on the results.
Pricing. $299 a year, plus taxes where applicable.
Pros
- Screens and articles in one place.
- Quant ratings as a filter.
Cons
- You rely on its rating method rather than your own fields.
- More expensive than Finviz Elite.
Verdict: Suits investors who want ratings and reading, not raw filters.
9. Morningstar Investor
What it does. Morningstar's individual investor service, with screening tools, independent analysis and ratings, and portfolio insights.
Best for. Long-term investors who want to screen on analyst ratings across stocks and funds.
Pricing. $34.95 a month or $249 a year, with a seven-day free trial.
Pros
- Screens tied to a consistent rating method.
- Fund and ETF coverage.
Cons
- Fewer technical and short-term filters.
- Not built for event-driven screens.
Verdict: A good fit for rating-led, long-term screening.
10. Zacks Premium
What it does. The paid tier of Zacks Investment Research, known for the Zacks Rank, which is based on earnings estimate revisions, and a library of predefined screens.
Best for. Investors who want screens built around analyst estimate changes.
Pricing. See the vendor's pricing page. The Zacks site blocked our request on October 5, 2026.
Pros
- Many ready-made screens.
- One explained signal behind the main rating.
Cons
- We could not confirm current features or price on the vendor's site today.
- Narrow signal set.
Verdict: Worth checking if estimate revisions drive your process.
Where Dombey falls short
The Daily Phoenix Screener is not a Finviz replacement in the usual sense. Its limits:
- Narrow coverage. Special situations and dated catalysts only. It will not screen the whole market for you.
- No data terminal. No custom filters, no general stock database and no export. You still want a tool like Stock Rover, Koyfin or TIKR, and SEC EDGAR, for your own work.
- Top tier only. The screener is part of Founding Membership, not the $6.67 Standard Access tier.
- Small team. The number of situations covered at any time is limited.
- Pen-name author. The research is published under a pen name, which some readers prefer not to rely on.
- Short history. The archive is young, so there is less record to examine than older services offer.
Free vs paid
Free plans go further than most people expect. Finviz, Koyfin, TIKR, TradingView, Stock Rover, Yahoo Finance and Simply Wall St all let you screen without paying, within limits. For value screens on US stocks, Finviz's free plan is often enough, and our guide on the best stock screeners for value investors compares the balance-sheet filters in detail.
Paying makes sense when one of these limits gets in the way:
- If you need more than 3 years of statements, Finviz Elite, Koyfin Plus, TIKR Plus or Stock Rover Premium Plus.
- If you need global stocks, Koyfin, TIKR or TradingView.
- If you need custom formulas, Koyfin Premium or Stock Rover.
- If you want a daily shortlist of special situations with a catalyst ahead, Dombey's Founding Membership.
How to choose
Run the same screen on two free plans before deciding. A simple test is stocks with a price-to-book below 1 and more cash than debt, which shows how each tool handles balance-sheet fields.
| Your situation | Pick | Add later when |
|---|---|---|
| You screen for special situations before a catalyst | Dombey Daily Phoenix ScreenerTop pick | You want your own filters: add Stock Rover or Koyfin |
| You want more metrics than Finviz | Stock Rover | You need global stocks: add TIKR |
| You screen global stocks or use formulas | Koyfin | You want charts: add TradingView |
| You screen from charts | TradingView | You want long histories: add TIKR |
| You are newer and want explanations | Simply Wall St | You want a house view: add Morningstar Investor |
For how filters translate into a list of real events, see what a stock catalyst is, and for a side-by-side of the four best-known self-serve tools, read Finviz vs TradingView vs Koyfin vs Stock Rover.
The bottom line
Dombey's Daily Phoenix Screener is our top pick for investors who screen for special situations before a dated catalyst, as a curated daily shortlist inside Founding Membership. For a self-serve Finviz replacement, Stock Rover offers the most metrics, Koyfin the most flexible global screens, TradingView the best chart-led screening and TIKR the longest histories for the price. Most have free plans, so test the same screen on two before paying. Pick the tool that removes the specific Finviz limit you hit.